Header Logo

Connection

Zoe Arvanitakis to tau Proteins

This is a "connection" page, showing publications Zoe Arvanitakis has written about tau Proteins.
Connection Strength

1.616
  1. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.672
  2. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord. 2007 May; 13(4):230-9.
    View in: PubMed
    Score: 0.273
  3. Recent advances in the understanding of tau protein and movement disorders. Curr Opin Neurol. 2001 Aug; 14(4):491-7.
    View in: PubMed
    Score: 0.187
  4. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.181
  5. Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol. 2018 06; 44(4):347-362.
    View in: PubMed
    Score: 0.148
  6. Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Parkinsonism Relat Disord. 2003 Jun; 9(5):265-70.
    View in: PubMed
    Score: 0.053
  7. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.039
  8. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.034
  9. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 2014 Nov; 128(5):679-89.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.